Work

Clinical Course of Patients with Non–Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon 19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib

Year: 2006

Type: article

Study design: Observational Study

Source: Clinical Cancer Research

DOI: 10.1158/1078-0432.ccr-05-1846

Authors: Gregory J. Riely, William Pao, DuyKhanh Pham, Allan R. Li, Naiyer Rizvi, Ennapadam S. Venkatraman, Maureen F. Zakowski, Mark G. Kris, Marc Ladanyi, Vincent A. Miller

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G5600330673, Investigational Cancer Therapeutics Training Program (ICTTP)

OpenAlex ID: W2168554121

FWCI: 49.07

Cites: 32

Cited by: 732

Related to: 10